Conference Date & Venue
Hilton Philadelphia City Avenue
Support Construction of Binaytara's Cancer Hospital in Nepal
Event Description
Join leading hematology and oncology experts in Philadelphia on Saturday, September 26, 2026, for a comprehensive, case-based educational conference focused on the latest advances in hematologic malignancies. This one-day summit delivers cutting-edge insights into multiple myeloma, acute leukemias, myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN), chronic leukemias, and lymphomas.
Designed to improve clinical decision-making and patient outcomes, the program features expert-led sessions, real-world case discussions, and in-depth analysis of evolving treatment paradigms, including CAR T-cell therapy, bispecific antibodies, menin inhibitors, JAK inhibitors, and next-generation targeted therapies.
Attendees will gain practical guidance on managing complex cases such as relapsed/refractory disease, TP53-mutated MDS/AML, and treatment sequencing across disease states. The conference also highlights efforts to address disparities in cancer care and expand access to innovative therapies beyond tertiary centers.
This interactive meeting provides a unique opportunity to engage with nationally recognized faculty, explore emerging data, and apply evidence-based strategies in hematologic oncology practice.
Target Audience
- Hematologists / Oncologists
- Surgical Oncologists
- Radiation Oncologists
- Oncology Fellows
- Oncology Nurses
- Nurse Practitioners
- Physician Assistants
- Oncology Pharmacists
Contact Us
Phone: 425-361-0029
Email: sponsorships@binaytara.org
About Binaytara
Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.
As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.
As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.
We invite companies interested in improving equitable access to cancer care to support our efforts.